A strong showing for tirzepatide
Eli Lilly's glucagon-like peptide-1 receptor agonist reduced A1C and body weight in adults with type 2 diabetes in Phase 3 SURPASS trials
diabetes
Getting the lowdown on GLO2
Researchers publish new data on the enzyme glyoxalase II and its role in cellular metabolism
